NCT03151967View on ClinicalTrials.gov

Lactobacillus Probiotic for Prevention of UTI

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 5, 2017

Study Completion Date

April 5, 2017

Conditions
Urinary Tract Infections (UTI's)
Interventions
DRUG

Lactobacillus crispatus CTV-05

vaginal applicator with medium containing drug

DRUG

Placebo

vaginal applicator with medium containing no drug

Trial Locations (2)

98115

Hall Health Primary Care Center, Seattle

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Washington

OTHER

NCT03151967 - Lactobacillus Probiotic for Prevention of UTI | Biotech Hunter | Biotech Hunter